Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches.
Although oral vaccination has numerous advantages over parenteral injection, degradation of the vaccine in the gut and low uptake in the lymphoid tissue of the gastrointestinal tract still complicate the development of oral vaccines. In this study chitosan microparticles were prepared and characterized with respect to size, zeta potential, morphology and ovalbumin-loading and -release. Furthermore, the in vivo uptake of chitosan microparticles by murine Peyer's patches was studied using confocal laser scanning microscopy (CLSM). Chitosan microparticles were made according to a precipitation/coacervation method, which was found to be reproducible for different batches of chitosan. The chitosan microparticles were 4.3+/-0.7 microm in size and positively charged (20+/-1 mV). Since only microparticles smaller than 10 microm can be taken up by M-cells of Peyer's patches, these microparticles are suitable to serve as vaccination systems. CLSM visualization studies showed that the model antigen ovalbumin was entrapped within the chitosan microparticles and not only associated to their outer surface. These results were verified using field emission scanning electron microscopy, which demonstrated the porous structure of the chitosan microparticles, thus facilitating the entrapment of ovalbumin in the microparticles. Loading studies of the chitosan microparticles with the model compound ovalbumin resulted in loading capacities of about 40%. Subsequent release studies showed only a very low release of ovalbumin within 4 h and most of the ovalbumin (about 90%) remained entrapped in the microparticles. Because the prepared chitosan microparticles are biodegradable, this entrapped ovalbumin will be released after intracellular digestion in the Peyer's patches. Initial in vivo studies demonstrated that fluorescently labeled chitosan microparticles can be taken up by the epithelium of the murine Peyer's patches. Since uptake by Peyer's patches is an essential step in oral vaccination, these results show that the presently developed porous chitosan microparticles are a very promising vaccine delivery system.
Leiden/Amsterdam Center for Drug Research, Division of Pharmaceutical Technology, Leiden, Netherlands.
I M
IM
van der Lubben
J C
JC
Verhoef
A C
AC
van Aelst
G
G
Borchard
H E
HE
Junginger
D000284:Administration, Oral; D000818:Animals; D001693:Biological Transport, Active; D002214:Capsules; D002686:Chitin / Q000008:administration & dosage* / Q000031:analogs & derivatives / Q000302:isolation & purification / Q000493:pharmacokinetics*; D048271:Chitosan; D005260:Female; D051379:Mice; D008807:Mice, Inbred BALB C; D018613:Microscopy, Confocal; D008855:Microscopy, Electron, Scanning; D010047:Ovalbumin / Q000008:administration & dosage / Q000493:pharmacokinetics; D010316:Particle Size; D010581:Peyer's Patches / Q000378:metabolism*; D014611:Vaccination
D002214:Capsules; D002686:Chitin; D010047:Ovalbumin; D048271:Chitosan